Primary Biliary Cirrhosis Flashcards
(8 cards)
What are the examination findings of primary biliary cirrhosis?
What are PBC specific features to look out for?
Middle aged female Pruritus, jaundice Hypercholesterolaemia Hepatomegaly +/- splenomegaly Cirrhosis features and complications Metabolic bone disease Proximal myopathy Other autoimmune conditions
Occurs in middle aged female (75-90%)
- Fatigue
- Hyperbilirubinaemia - jaundice, pruritus
- Generalised hyperpigmentation, worse over araes of exfoliation and lichenification - melanin deposit
- Clubbing
- Hypercholesterolaemia - xanthalesma, tendon xanthomata
- Coagulopathy - petechiae, ecchymoses
- Altered sex hormones - spider naevi
-
Hepatomegaly smooth and non-tender +/- hepatic venous hum
8A. Splenomegaly and ascites in portal hypertension - Complications of cirrhosis - hepatic encephalopathy, portal hypertension
- To comment as isolated hepatomegaly or chronic liver disease if unable to elicit additional features
PBC specific features:
1. Metabolic bone disease - kyphosis, fractures, osteoporosis
2. Proximal myopathy/osteomalacia (proximal muscle wasting and weakness)
3. Autoimmune disease
What are the definitive investigations for PBC?
- Serum anti-mitochondrial antibodies - positive in 95%
- 5% negative requiring PBC-specific autoantibodies (sp100, gp210)
- HLA DR8 - Blood tests
A. LFT - cholestatic picture (high GGT, ALP, mild ALT, AST, hyperbilirubinaemia)
- Some patients have AIH overlap ALT > 5x UL
B. IgM - raised
C. Lipid panel - hypercholesterolaemia
D. FBC - mono-pancytopenia - Liver biopsy if required
- Histology: portal tract granuloma, cirrhosis - US HBS, ERCP/MRCP to exclude extra-hepatic cholestasis (stones)
Which drugs can cause cholestasis?
Phenothiazines
Sulphonamides
Penicillins
Rifampicin
Macrolides
Carbamazepine
Androgenic steroids
Diclofenac
What is the management of primary biliary cirrhosis and its complications?
- Involvement of multidisciplinary team
- Supplement of fat soluble vitamins - A, D, E, K
- Treatment of bone disease/osteoporosis (vitamin D, calcium, bisphosphonates)
- Treatment of hypercholesterolaemia
- Treatment of liver disease (ursodeoxycholic acid improves liver biochemistry and slows disease progression)
- Management of pruritis (colestyramine, rifampicin, naltrexone)
- Anti-histamines do not work and may worsen encephalopathy - Management of fatigue (manage co-existent anaemia and hypothyroidism)
- Referral for transplantation (bilirubin >50, refractory fatigue or pruritis)
- Recurrence in graft 15% at 3 years, 30% at 10 years
What are the autoimmune conditions associated with PBC?
What are the features to look out for?
- Graves: goitre, eye signs, thyroid acropachy, pretibial myxedema, hypo/hyperthyroidism
- Sjogren: dry mouth, dry eyes
- RA: symmetrical deforming arthropathy, eye signs
- Scleroderma: telangiectasia, tight shiny skin, sclerodactyly, calcinosis, dystrophic nails
- Dermatomyositis: heliotrope rash, Gottron papules
- Idiopathic ILD: bibasal crepitations
- MG: myasthenic facies, psotsis, proximal weakness, fatigability
- Vitiligo: hypopigmented patches
- Atrophic gastritis: pallor, koilonychia, IDA
What are the typical presentation/features of PBC?
(demography, symptoms and signs)
- Middle aged women (women > men 9:1)
- Fatigue
- Debilitating pruritus and jaundice
- Hypercholesterolaemia
- Liver disease occurs late
Describe the pathogenesis of PBC
- Anti-mitochondrial antibodies (AMA) as molecular mimicry
- Likely from recurrent exposure to E. coli infections
- AM antigens expressed on biliary epithelial cells
- T cell mediated autoimmune attack against biliary cells - Chronic non-suppurative destructive cholangitis
- Necrotising inflammatory process of portal tracts
- Medium and small bile ducts infiltrated with lymphocytes, duct destruction
- Mild fibrosis and bile stasis - Reduction of bile ducts, proliferation of smaller bile tubules
- Increased fibrosis, expansion of periportal fibrosis to bridging fibrosis - Development of cirrhosis
What are the complications of PBC?
- Malabsorption - osteomalacia, coagulopathy
- Thromboembolism - anti-thrombin antibodies
- Sicca syndrome (70%)
- Cirrhosis, portal hypertension and complications
- Hepatocellular carcinoma (20x risk)